These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 4151248

  • 1. The central effects of the beta-adrenergic blocking agent INPEA.
    Ilyutchenok RYu, Gilinsky MA, Yeliseyeva AG, Jivotikoff BP, Loskutova LV, Pastoukhoff YuF.
    Neuropharmacology; 1972 Sep; 11(5):609-14. PubMed ID: 4151248
    [No Abstract] [Full Text] [Related]

  • 2. A reappraisal of the actions of noradrenaline and 5-hydroxytryptamine on cerebral cortical neurons.
    Frederickson RC, Jordan LM, Phillis JW.
    Comp Gen Pharmacol; 1972 Dec; 3(12):443-56. PubMed ID: 4146860
    [No Abstract] [Full Text] [Related]

  • 3. Effects of the adrenergic receptor blocking agents on the ganglionic transmission.
    Kayaalp SO, McIsaac RJ.
    Eur J Pharmacol; 1969 Sep; 7(3):264-9. PubMed ID: 4390872
    [No Abstract] [Full Text] [Related]

  • 4. Effect of beta-adrenergic blocking agents on the spontaneous motility of mice.
    Fabian HE, Izquierdo JA.
    Arzneimittelforschung; 1972 Aug; 22(8):1375-6. PubMed ID: 4404659
    [No Abstract] [Full Text] [Related]

  • 5. Effect of intraperitoneal administration of (+)-INPEA on oxytocin and prostaglandin evoked responses of the isolated rat uterus.
    Rao VS, Sharma PL.
    Br J Pharmacol; 1973 Jun; 48(2):344P-345P. PubMed ID: 4147431
    [No Abstract] [Full Text] [Related]

  • 6. Mechanism of anti-inflammatory activity of -adrenoceptor blocking agents.
    Bhalla TN, Sinha JN, Tangri KK, Bhargava KP.
    Eur J Pharmacol; 1972 Dec; 20(3):366-8. PubMed ID: 4404943
    [No Abstract] [Full Text] [Related]

  • 7. Pharmacological and behavioral characteristics of 3-4, dimethoxyphenylethamine and its n-acetyl derivative.
    Bindler E, Sanghvi I, Gershon S.
    Arch Int Pharmacodyn Ther; 1968 Nov; 176(1):1-10. PubMed ID: 4387864
    [No Abstract] [Full Text] [Related]

  • 8. Effect of - and -adrenergic blocking agents and para-chlorophenylalanine on morphine- and caffeine-stimulated locomotor activity of mice.
    Estler CJ.
    Psychopharmacologia; 1973 Nov; 28(3):261-8. PubMed ID: 4144146
    [No Abstract] [Full Text] [Related]

  • 9. A study of the effect of 3,4-dimethoxyphenylethylamine on cortical evoked potentials in the rat.
    Dear EM, Malcolm JL.
    Int J Neuropharmacol; 1967 Nov; 6(6):529-42. PubMed ID: 5588692
    [No Abstract] [Full Text] [Related]

  • 10. [Central effect of beta-phenyl ethylamines derivatives. 1. Effect of intracerebral administration of beta-phenylethylamine derivatives on behavioral changes in mice].
    Sakurada S, Tadano T, Shima K, Kisara K.
    Nihon Yakurigaku Zasshi; 1972 Nov; 68(6):619-25. PubMed ID: 4676607
    [No Abstract] [Full Text] [Related]

  • 11. The effects of beta adrenoceptor blocking agents on the membrane potential and spike generation in the smooth muscle of guinea-pig taenia coli.
    Davis WG.
    Br J Pharmacol; 1970 Jan; 38(1):12-9. PubMed ID: 4391730
    [Abstract] [Full Text] [Related]

  • 12. The effect of beta-adrenergic blocking agents on the rat adrenal phenylethanolamine-N-methyltransferase activity.
    Janiec W, Lukas W, Glogowski A.
    Pol J Pharmacol Pharm; 1973 Jan; 25(3):237-41. PubMed ID: 4150017
    [No Abstract] [Full Text] [Related]

  • 13. The antiarrhythmic effects of quaternary salts of beta-adrenergic blocking agents.
    Lahiri PK, Hardman HF.
    Arch Int Pharmacodyn Ther; 1974 Aug; 210(2):197-211. PubMed ID: 4155279
    [No Abstract] [Full Text] [Related]

  • 14. Beta-blocking drugs and human platelet aggregation in vitro.
    Gibelli A, Montanari C, Bellani D, Mandelli V, Sacchetti G.
    Experientia; 1973 Feb 15; 29(2):186-7. PubMed ID: 4144249
    [No Abstract] [Full Text] [Related]

  • 15. Conformation effects on the activity of drugs. 4. Cyclic analogs of 1-(p-nitrophenyl)-2-isopropylaminoethanol. Synthesis and evaluation of the adrenergic beta-receptor blocking activity of 2-(p-nitrophenyl)-4-isopropylmorpholine.
    Balsamo A, Crotti P, Macchia B, Macchia F, Del Tacca M, Mazzanti L.
    J Med Chem; 1973 Mar 15; 16(3):224-7. PubMed ID: 4147387
    [No Abstract] [Full Text] [Related]

  • 16. A comparison of the local anaesthetic-, "quinidine-like"- and adrenergic beta-blocking-activities of five beta-receptor antagonists.
    Davis WG.
    J Pharm Pharmacol; 1970 Apr 15; 22(4):284-90. PubMed ID: 4392570
    [No Abstract] [Full Text] [Related]

  • 17. Further evidence for a role of 2-phenylethylamine in the mode of action of delta 9-tetrahydrocannabinol.
    Sabelli HC, Pedemonte WA, Whalley C, Mosnaim AD, Vazquez AJ.
    Life Sci; 1974 Jan 01; 14(1):149-56. PubMed ID: 4810493
    [No Abstract] [Full Text] [Related]

  • 18. Protection against isoprenaline induced myocardial necroses by beta-adrenergic blocking agents.
    Kulig A, Kostka-Trabka E, Gryglewski R.
    Pol J Pharmacol Pharm; 1973 Jan 01; 25(1):85-90. PubMed ID: 4149575
    [No Abstract] [Full Text] [Related]

  • 19. Behavioral and electrophysiological effects of phenylethanolamine and 2-phenylethylamine.
    Sabelli HC, Vazquez AJ, Flavin D.
    Psychopharmacologia; 1975 May 28; 42(2):117-25. PubMed ID: 1161972
    [Abstract] [Full Text] [Related]

  • 20. Central actions of some beta-adrenoceptor blocking agents.
    Shah UH, Jindal MN, Patel VK, Kelkar VV.
    Arzneimittelforschung; 1974 Oct 28; 24(10):1581-4. PubMed ID: 4154760
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.